Literature DB >> 1644029

Prevalence of headache and migrainous headache in Nigerian Africans: a community-based study.

B O Osuntokun1, A O Adeuja, V A Nottidge, O Bademosi, A O Alumide, O Ige, F Yaria, B S Schoenberg, C L Bolis.   

Abstract

In a door-to-door survey in a Nigerian town with stable population of about twenty thousand, 18,594 subjects were screened with a questionnaire, which involved a complete census, administered by non-doctor, including primary health care personnel. Migrainous headache was diagnosed on the basis of combination of responses to the questionnaire shown in a pilot study validated by neurological examination to have 92% sensitivity and 99% specificity. Crude life time prevalence ratio of at least one episode of headache unspecified was 51 percent (50% in males and 52% in females). The crude prevalence ratio of migrainous headache was 5.3 per 100 (5 per 100 in males and 5.6 per 100 in females), with peak age-specific prevalence ratios in the first decade in both males and females. Migrainous headache was three times as common in females as in males in the second and third decades. Prevalence of migrainous headache in Nigerian Africans appears less than in Caucasians. No social status was at special risk to developing migrainous headache.

Entities:  

Mesh:

Year:  1992        PMID: 1644029

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  8 in total

Review 1.  The prevalence of headache may be related with the latitude: a possible role of Vitamin D insufficiency?

Authors:  Sanjay Prakash; Nivedita C Mehta; Ajay S Dabhi; Om Lakhani; Madhuri Khilari; Nilima D Shah
Journal:  J Headache Pain       Date:  2010-05-13       Impact factor: 7.277

2.  Usefulness of the SF-8 Health Survey for comparing the impact of migraine and other conditions.

Authors:  Diane M Turner-Bowker; Martha S Bayliss; John E Ware; Mark Kosinski
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

3.  Improving quality in population surveys of headache prevalence, burden and cost: key methodological considerations.

Authors:  Timothy J Steiner; Lars Jacob Stovner; Mohammed Al Jumah; Gretchen L Birbeck; Gopalakrishna Gururaj; Rigmor Jensen; Zaza Katsarava; Luiz Paulo Queiroz; Ann I Scher; Redda Tekle-Haimanot; Shuu-Jiun Wang; Paolo Martelletti; Tarun Dua; Somnath Chatterji
Journal:  J Headache Pain       Date:  2013-10-25       Impact factor: 7.277

4.  Headache prevalence and its characterization amongst hospital workers in Enugu, South East Nigeria.

Authors:  Ikenna Onwuekwe; Tonia Onyeka; Emmanuel Aguwa; Birinus Ezeala-Adikaibe; Oluchi Ekenze; Elias Onuora
Journal:  Head Face Med       Date:  2014-11-25       Impact factor: 2.151

5.  Estimating the association between being seropositive for cysticercosis and the prevalence of epilepsy and severe chronic headaches in 60 villages of rural Burkina Faso.

Authors:  Ida Sahlu; Hélène Carabin; Rasmané Ganaba; Pierre-Marie Preux; Assana Kone Cissé; Zekiba Tarnagda; Sarah Gabriël; Veronique Dermauw; Pierre Dorny; Cici Bauer; Athanase Millogo
Journal:  PLoS Negl Trop Dis       Date:  2019-01-24

6.  Magnetic resonance imaging in chronic headache: our experiences and perspectives.

Authors:  Ukamaka Dorothy Itanyi; Philip Chinedu Okere; Nneka Ifeyinwa Iloanusi; Felix U Uduma
Journal:  Afr Health Sci       Date:  2020-09       Impact factor: 0.927

7.  Primary headache disorders at a tertiary health facility in Lagos, Nigeria: prevalence and consultation patterns.

Authors:  Olajumoke Oshinaike; Oluwadamilola Ojo; Njideka Okubadejo; Olaitan Ojelabi; Akinola Dada
Journal:  Biomed Res Int       Date:  2014-01-23       Impact factor: 3.411

8.  Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria.

Authors:  Kolawole Wahab; Asuwemhe Ugheoke; Peter Okokhere; Titus Ibekwe
Journal:  Ethiop J Health Sci       Date:  2016-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.